TickerFactsScreenerDevelopers

Akari Therapeutics Plc (AKTX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2004: $02009: $3.0K2010: $9.0K2011: $6.0K2012: $1.10M2013: $553.7K2014: $3.33M2015: $68.92M2016: $34.10M2017: $28.11M2018: $5.45M2019: $5.73M2020: $14.06M2021: $9.36M2022: $13.25M2023: $3.85M2024: $02025: $0$0
2004Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$0—
2024$0-100.0%
2023$3.85M-71.0%
2022$13.25M+41.5%
2021$9.36M-33.4%
2020$14.06M+145.2%
2019$5.73M+5.2%
2018$5.45M-80.6%
2017$28.11M-17.6%
2016$34.10M-50.5%
2015$68.92M+1971.2%
2014$3.33M+501.0%
2013$553.7K-49.9%
2012$1.10M+18300.0%
2011$6.0K-33.3%
2010$9.0K+200.0%
2009$3.0K—
2004$0—